High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes
about
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcomaGermline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.Using high-throughput sequencing transcriptome data for INDEL detection: challenges for cancer drug discovery.Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.Theranostic Profiling for Actionable Aberrations in Advanced High Risk Osteosarcoma with Aggressive Biology Reveals High Molecular Diversity: The Human Fingerprint HypothesisHigh-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations.Epidemiology and therapies for metastatic sarcomaClinical and biological significance of PIM1 kinase in osteosarcoma.Targeting osteosarcoma.Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaA new approach for prediction of tumor sensitivity to targeted drugs based on functional dataWhole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data.Network analysis of microRNAs and genes in human osteosarcoma.A six-microRNA set as prognostic indicators for bile duct cancerThe molecular landscape of extraskeletal osteosarcoma: A clinicopathological and molecular biomarker study.Variation in PTCHD2, CRISP3, NAP1L4, FSCB, and AP3B2 associated with spherical equivalent.Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomasRapid screening of novel agents for combination therapy in sarcomasMutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas.Dissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration.Role of genetic and molecular profiling in sarcomas.BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma.Molecular profiling of sarcomas: new vistas for precision medicine.miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.Integration of genomic, transcriptomic and functional profiles of aggressive osteosarcomas across multiple species.Clinical Relevance of Genomic Changes in Recurrent Pediatric Solid Tumors
P2860
Q26738598-1FEFADF6-61A8-4AEA-A4C1-6E1D61B58CBBQ30235105-D55B124D-46AC-40D8-AAE6-79F0CB8C9FFAQ31038214-06C11ED9-E568-4C3B-8005-36680DFEEC48Q33275318-8A67A9F1-7645-4209-A550-A8D21685380AQ33768759-CB2C812C-3C83-4F87-9A38-58678C8CA5B9Q33872384-D2725ED5-A7E3-4B25-8C80-399D1C19C045Q34025926-58FDDBB0-5285-4405-ACD3-5FAFCB5EC53EQ34369027-612DA876-07ED-4339-A2B5-71D98242BC4FQ34652142-D6743623-7133-495A-803C-C4735481A2E5Q34674917-2F51D019-38F7-4D47-9565-2B4A9BE72216Q34792994-4CC44681-E6A9-4E9C-9292-466F380E682EQ34793401-ED1CE5F8-6CFA-4423-8115-8B0A21A1E6E4Q34869180-3D03F5EF-3A2F-44A3-9684-84DBF45CAD74Q35511058-94EC8907-CC64-4E08-8132-F2BCE98ADBAFQ36081276-C2FFC991-C359-4FAD-B80E-150CAAE8A96AQ36411472-7255F53D-2D39-4203-A32D-E78ACBB78656Q36873828-92032FB7-1054-4F6F-974A-2FCFD881C256Q37095316-C676CEED-7766-4097-BCE4-EBA43B2FD3C8Q37225394-F53DEC7D-0BC4-4E0B-8E94-6F259788FAB5Q37298877-D8B7AF0E-4EA6-4C8C-B30D-29EB65EC8383Q37371256-52CB3D33-8A07-4789-A83B-E562B9A29ABFQ38103561-299BAF0F-5C8F-4F73-BFE4-5BDA50A5844BQ38458016-EE74BA47-BB94-4B24-B487-29E6D81644F2Q38981617-BE012C0E-5529-4773-98DB-3A23B02A6DEEQ39406356-D91D4742-7FC1-4D71-B0C3-54C060D24741Q41975973-EF087821-8DDD-440E-B947-FD85E2ED1B52Q44077895-635A4FF6-3D0D-40AD-ADAC-7A3FA3B03F81Q58751530-C77A344A-E285-4A7F-B99D-9F9BE9A8EAEE
P2860
High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@ast
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@en
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@nl
type
label
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@ast
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@en
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@nl
prefLabel
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@ast
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@en
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@nl
P2093
P2860
P356
P1433
P1476
High-throughput genotyping in ...... e-3-kinase and other oncogenes
@en
P2093
David Harmon
Francis Hornicek
Laura MacConaill
Levi Garraway
Zeeshan Tariq
P2860
P304
P356
10.1002/CNCR.26617
P407
P577
2011-10-17T00:00:00Z